Cite
The Impact of the Hybridoma Technology on the RD of Idiotypic Antibodies
MLA
Heinz Kohler. “The Impact of the Hybridoma Technology on the RD of Idiotypic Antibodies.” Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, vol. 40, no. 1, Feb. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4046ca801bca6c885e5b801a210bc184&authtype=sso&custid=ns315887.
APA
Heinz Kohler. (2021). The Impact of the Hybridoma Technology on the RD of Idiotypic Antibodies. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 40(1).
Chicago
Heinz Kohler. 2021. “The Impact of the Hybridoma Technology on the RD of Idiotypic Antibodies.” Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 40 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4046ca801bca6c885e5b801a210bc184&authtype=sso&custid=ns315887.